About COBO Technologies
COBO Technologies is a company based in Copenhagen (Denmark) founded in 2017 by Jens Ole Bock and Eric Paul Bennett.. COBO Technologies has raised $270.36 thousand across 2 funding rounds. The company has 1 employees as of November 30, 2024. COBO Technologies operates in a competitive market with competitors including Beam Therapeutics, Avidity Biosciences, eGenesis, Univercells and Sutro Biopharma, among others.
- Headquarter Copenhagen, Denmark
- Employees 1 as on 30 Nov, 2024
- Founders Jens Ole Bock, Eric Paul Bennett
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cobo Technologies Aps
-
Annual Revenue
-
Net Profit
$-108.57 K (USD)62as on Dec 31, 2022
-
EBITDA
$-135.99 K (USD)63as on Dec 31, 2022
-
Total Equity Funding
$270.36 K (USD)
in 2 rounds
-
Latest Funding Round
$231.16 K (USD), Seed
Apr 29, 2019
-
Investors
-
Employee Count
1
as on Nov 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of COBO Technologies
COBO Technologies has successfully raised a total of $270.36K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $231.16 thousand completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $231,161
-
First Round
First Round
(06 Jul 2018)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2019 | Amount | Seed - COBO Technologies | Valuation |
investors |
|
| Jul, 2018 | Amount | Seed - COBO Technologies | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by COBO Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - COBO Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cobo Technologies Comparisons
Competitors of COBO Technologies
COBO Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beam Therapeutics, Avidity Biosciences, eGenesis, Univercells and Sutro Biopharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of gene therapy using CRISPR base editing to treat diseases
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Gene transplantation platform for humanizing pig cells is developed.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about COBO Technologies
When was COBO Technologies founded?
COBO Technologies was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is COBO Technologies located?
COBO Technologies is headquartered in Copenhagen, Denmark.
Who is the current CEO of COBO Technologies?
Jens Ole Bock is the current CEO of COBO Technologies. They have also founded this company.
Is COBO Technologies a funded company?
COBO Technologies is a funded company, having raised a total of $270.36K across 2 funding rounds to date. The company's 1st funding round was a Seed of $39.2K, raised on Jul 06, 2018.
How many employees does COBO Technologies have?
As of Nov 30, 2024, the latest employee count at COBO Technologies is 1.
What does COBO Technologies do?
COBO Technologies was founded in 2017 in Copenhagen, Denmark, and operates in the biotechnology sector focused on genome editing. Products and services for editing genomes and controlling quality in CRISPR-modified cells and animals are offered. A proprietary CRISPR INDEL profiling platform, known as CIPP, has been developed for mutation analysis and protein expression profiling. Additionally, PIPPR technology has been launched for label-free SWATH LC-MS-based protein and proteome expression profiling.
Who are the top competitors of COBO Technologies?
COBO Technologies's top competitors include Sutro Biopharma, eGenesis and Avidity Biosciences.
What is COBO Technologies's valuation?
The valuation of COBO Technologies is $2.25M as of Apr 2019.